Asia
SSY Group Gets Bulk Drug Approval for Edema Drug in China
SSY Group's (HKG:2005) furosemide was approved for registration by China's National Medical Products Administration to become a bulk drug for preparation on the market, according to a Tuesday Hong Kong bourse filing.The product is mainly used to treat various diseases with edema, hypertension, hyperkalemia and hypercalcemia.
HKG:2005
